Glasdegib - Isotope Labelled Standards
References
FAQ's
References
- Munchhof, Michael J.; Reiter, Lawrence A.; La Greca, Susan D.; Jones, Christopher S.; Li, Qifang, Benzimidazole derivatives, Pfizer Inc., United States, US8148401B2, April 3, 2012
- Satyanarayana, P.; Bajivali, Sk.; Usharani, M.; Mohan, S., A new way of method establish and validated of related substance of glasdegib by RP-HPLC and its forced degradation study, International Journal of Pharmaceutical Sciences and Research, Volume: 12, Issue: 3, Pages: 1599-1607, 2021
Frequently Asked Questions
Are Glasdegib impurities tested for potential toxicity?
Yes, impurities in Glasdegib undergo toxicity testing to assess their potentially harmful effects. These tests help determine their safety profile and establish acceptable limits to ensure patient safety.
How are impurity levels in Glasdegib regulated during commercial production?
During commercial production of Glasdegib, strict regulation of impurity levels is done through quality control measures. Batch testing, validation of manufacturing processes, and compliance with regulatory guidelines help ensure consistent quality and safety of the drug.
Which solvent helps in analyzing Glasdegib impurities?
Methanol is a common solvent used when analyzing many impurities in Glasdegib.
How should Glasdegib impurities be stored in terms of temperature?
The recommendation is to store Glasdegib impurities at a controlled room temperature, within 2-8 °C.
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.